How does medical technology revolutionize commercial health insurance?

2024-02-28 / GlobalBio & Investment

#MedicalInsuranceDidyouknowthattheaveragepersoninTaiwanhasthreeinsurancepolicies?Withtheriseofemergingmedicaltechnology,commercialhealthinsuranceisbeingrevolutionized.In2023,theBio-TaiwanCommittee(#BT...

GBIHighlights

Leadgene Biomedical, Inc.'s LEADGENE® IS ELISA Kit has been approved by Taiwan's FDA...

2024-02-28 / GlobalBio & Investment

#TFDAApprovalExcitingnews!LeadgeneBiomedical,Inc.'sLEADGENE®IndoxylSulfate(IS)ELISAKit,aCE-markedprotein-boundtoxindiagnosiskit,hasbeenapprovedbyTaiwan'sFDAasaClassIIIinvitrodiagnosticdevi...

GBIHighlights

Nine biopharma companies have announced record-high revenues for January

2024-02-28 / GlobalBio & Investment

#BiotechGrowthExcitingnewsfromthe#biopharmasector!Ninebiopharmacompanieshaveannouncedrecord-highrevenuesforJanuary,indicatingaprosperousstarttotheyear.Amongthem,AnxoPharmaceuticalTaiwanCo.Ltd(6677.TWO...

GBIHighlights

FDA approves Onivyde® as a first-line therapy for metastatic pancreatic adenocarcinoma

2024-02-28 / GlobalBio & Investment

**#FDAApproval**ExcitingnewsforPharmaEngineInc(4162.TWO)!FDAapproves#Onivyde®asafirst-linetherapyformetastaticpancreaticadenocarcinoma,markingapotentialnewstandardofcare.PharmaEngine'scollabor...

GBIHighlights

The potential of next-generation microbiome therapy in clinical applications (8th AMC)

2024-02-28 / GlobalBio & Investment

*#MicrobiomeTherapy**Canthegutmicrobiotarevolutionizecancertreatment?Insightsfromthe8thAsiaMicrobiomeConference(#AMC),heldbyIBCAcademiaSinica,NationalTaiwanUniversityHospital,and圖爾思生物科技BIOTOOLSCO.,LTD...

GBIHighlights

Chang Gung Medical Foundation teams up with Gilead Sciences to accelerate early-stage clinical trial

2024-02-28 / GlobalBio & Investment

**#ClinicalTrials**ChangGungMedicalFoundationteamsupwithGileadSciencestoaccelerateearly-stageclinicaltrials,focusingon#oncology.Thecollaborationaimstoadvanceclinicaltrialsintumorresearch,preclinicalco...

GBIHighlights

GBI Spotlight: Dr. Han-Chung Wu

2024-02-28 / GlobalBio & Investment

#GBISpotlight:Dr.Han-ChungWu(吳漢忠)MeetDr.Han-ChungWu,themanbehindthedevelopmentofprecisiontherapythroughinnovativephagedisplaytechnology.AstheDirectorofBioTrecatNBRP,AcademiaSinica,heisawell-knownfigur...

GBIHighlights

Meet David Lee, the visionary founder and CEO of Singular Wings Medical

2024-02-28 / GlobalBio & Investment

**#Meet#StartupCEOs**MeetDavidLee(李維中),thevisionaryfounderandCEOofSingularWingsMedical.Fromtheelectronicsindustrytoentrepreneurship,hemerges#healthcarewith#electronics,craftinginnovativesolutionsforme...

GBIHighlights

Merck's Keytruda Leads 2023 Sales!

2024-02-28 / GlobalBio & Investment

**Merck'sKeytrudaLeads2023Sales!**Merck'sKeytrudaemergesasthetop-sellingdrugof2023,amassinganimpressive$25billioninsales.MerckCFOCarolineLitchfieldattributesKeytruda'ssurgein2023torecentap...

GBIHighlights

TBMC partners with U.S. firm National Resilience, Inc. for advanced bioprocessing

2024-02-28 / GlobalBio & Investment

**ExcitingNews!TaiwanBio-ManufacturingCorporation(#TBMC),the‘biotechTSMC,’partnerswithU.S.firmNationalResilience,Inc.foradvancedbioprocessing.ChairmanMichelChu(瞿志豪)outlinesaglobalapproachf...

GBIHighlights

AnBogen Therapeutics hits a milestone: completes USD 12.5M Series A funding round!

2024-02-28 / GlobalBio & Investment

**AnBogenTherapeuticshitsamilestone:completesUSD12.5MSeriesAfundinground!**InastrategicmoveledbyCDIBCapitalInternationalCorporation,AnBogenTherapeuticsproudlyannouncesthesuccessfulclosureofitsSeriesAf...

GBIHighlights

Revolutionizing Antibiotics: Xtraordinary Discovery by NCHU team!

2024-02-28 / GlobalBio & Investment

*RevolutionizingAntibiotics:XtraordinaryDiscoverybyNationalChungHsingUniversity(#NCHU)team!**NCHUresearchersmadeagroundbreakingdiscoveryinantibioticdevelopment.Theyfoundanucleotidesignalingmoleculetha...